The regional crossfire raised the risks that an interim agreement to halt fighting in the war could break down, putting the ...
Dr. Monty Pal compares the available immunotherapy plus tyrosine kinase inhibitor (IO/TKI) combination regimens for the first-line treatment of advanced renal cell carcinoma (RCC) and explains the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results